{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:59:47Z","timestamp":1791305987178,"version":"4.3.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T00:00:00Z","timestamp":1363910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00264-013-1856-y","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T00:24:38Z","timestamp":1363825478000},"page":"1375-1380","source":"Crossref","is-referenced-by-count":38,"title":["The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections"],"prefix":"10.1007","volume":"37","author":[{"given":"Kheeldass","family":"Jugun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vaudaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hoffmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"U\u00e7kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,22]]},"reference":[{"key":"1856_CR1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645\u20131654","journal-title":"N Engl J Med"},{"key":"1856_CR2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2007.02.012","volume":"30","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ (2007) Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents 30:202\u2013209","journal-title":"Int J Antimicrob Agents"},{"key":"1856_CR3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/jac\/dks119","volume":"67","author":"PS Corona P\u00e9rez-Cardona","year":"2012","unstructured":"Corona P\u00e9rez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farf\u00e1n E, Amat Mateu C, Flores Sanchez X (2012) Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. J Antimicrob Chemother 67:1749\u20131754","journal-title":"J Antimicrob Chemother"},{"key":"1856_CR4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s10096-011-1500-y","volume":"31","author":"J Parra-Ruiz","year":"2012","unstructured":"Parra-Ruiz J, Due\u00f1as-Guti\u00e9rrez C, Tom\u00e1s-Jim\u00e9nez C, Linares-Palomino JP, Garrido-Gomez J, Hern\u00e1ndez-Quero J (2012) Safety analysis of high dose (>6\u00a0mg\/kg\/day) daptomycin in patients with concomitant statin therapy. Eur J Clin Microbiol Infect Dis 31:1771\u20131774","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1856_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2334-12-133","volume":"12","author":"JC Gallagher","year":"2012","unstructured":"Gallagher JC, Huntington JA, Culshaw D, McConnell SA, Yoon M, Berbari E (2012) Daptomycin therapy for osteomyelitis: a retrospective study. BMC Infect Dis 12:133","journal-title":"BMC Infect Dis"},{"key":"1856_CR6","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/AAC.00038-12","volume":"56","author":"I Byren","year":"2012","unstructured":"Byren I, Rege S, Campanaro E, Yankelev S, Anastasiou D, Kuropatkin G, Evans R (2012) Randomized controlled trial of the safety and efficacy of daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty. Antimicrob Agents Chemother 56:5626\u20135632","journal-title":"Antimicrob Agents Chemother"},{"key":"1856_CR7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","volume":"15","author":"S Nguyen","year":"2009","unstructured":"Nguyen S, Pasquet A, Legout L, Beltrand E, Dubreuil L, Migaud H, Yazdanpanah Y, Senneville E (2009) Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect 15:1163\u20131169","journal-title":"Clin Microbiol Infect"},{"key":"1856_CR8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10156-012-0405-8","volume":"18","author":"M Shinjoh","year":"2012","unstructured":"Shinjoh M, Iketani O, Watanabe K, Shimojima N, Kudo M, Yamagishi H, Shimada H, Sugita K, Takahashi T, Mori T, Hasegawa N, Iwata S (2012) Safety and efficacy of linezolid in 16 infants and children in Japan. J Infect Chemother 18:591\u2013596","journal-title":"J Infect Chemother"},{"key":"1856_CR9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","volume":"8","author":"FP Tally","year":"1999","unstructured":"Tally FP, Zeckel M, Wasilewski MM, Carini C, Berman CL, Drusano GL, Oleson FB Jr (1999) Daptomycin: a novel agent for gram-positive infections. Expert Opin Investig Drugs 8:1223\u20131238","journal-title":"Expert Opin Investig Drugs"},{"key":"1856_CR10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1368-5031.2005.00885.x","volume":"60","author":"WV Kern","year":"2006","unstructured":"Kern WV (2006) Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections. Int J Clin Pract 60:370\u2013378","journal-title":"Int J Clin Pract"},{"key":"1856_CR11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","volume":"47","author":"BH Dvorchik","year":"2003","unstructured":"Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD (2003) Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47:1318\u20131323","journal-title":"Antimicrob Agents Chemother"},{"key":"1856_CR12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI (2004) The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38:1673\u20131681","journal-title":"Clin Infect Dis"},{"key":"1856_CR13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355:653\u2013665","journal-title":"N Engl J Med"},{"key":"1856_CR14","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.44.11.2948-2953.2000","volume":"44","author":"FB Oleson Jr","year":"2000","unstructured":"Oleson FB Jr, Berman CL, Kirkpatrick JB, Regan KS, Lai JJ, Tally FP (2000) Once-daily dosing in dogs optimizes daptomycin safety. Antimicrob Agents Chemother 44:2948\u20132953","journal-title":"Antimicrob Agents Chemother"},{"key":"1856_CR15","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.00047-09","volume":"53","author":"A-K John","year":"2009","unstructured":"John A-K, Baldoni D, Haschke M, Rentsch K, Schaerli P, Zimmerli W, Trampuz A (2009) Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 53:2719\u20132724","journal-title":"Antimicrob Agents Chemother"},{"key":"1856_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/dkg277","volume":"52","author":"P Vaudaux","year":"2003","unstructured":"Vaudaux P, Francois P, Bisognano C, Li D, Lew DP, Schrenzel J (2003) Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. J Antimicrob Chemother 52:89\u201395","journal-title":"J Antimicrob Chemother"},{"key":"1856_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2334-6-74","volume":"6","author":"HJ Schaad","year":"2006","unstructured":"Schaad HJ, Bento M, Lew DP, Vaudaux P (2006) Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection. BMC Infect Dis 6:74","journal-title":"BMC Infect Dis"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-013-1856-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00264-013-1856-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-013-1856-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:44:38Z","timestamp":1558701878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00264-013-1856-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,22]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s00264-013-1856-y","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,22]]}}}